MapLight Therapeutics, Inc.
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +14.8% | +17.7% | – | – | – | -18.1% | +0.0% | +2.9% | +15.7% | -9.3% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +45.9% | +1.8% | +8.7% | +23.2% | -5.3% | +36.1% | +1.4% | +138.0% | -16.7% | -0.5% | – | |
| – | +143.9% | +10.1% | -6.1% | -49.4% | +82.0% | +1.6% | +15.4% | +325.8% | -42.3% | -6.5% | – | |
| – | +59.0% | +3.5% | +5.5% | +9.0% | +2.6% | +30.6% | +3.2% | +164.3% | -22.7% | -1.5% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.